Future of Decision-Making: AI to Control 99% of Intelligence by Lilu Anderson 25.06.2024 Explore how AI could alter our future, from decision-making to daily life, based on expert insights from WEF Summer Davos. ...
Verizon Fined $1M for 2022 911 Outage, Agrees Compliance Plan by Mark Eisenberg 25.06.2024 Verizon to pay $1M fine for December 2022 911 outage affecting six states, vows improvements to ensure reliable emergency services.
Investing Now: Inflation, Bonds, and Crypto Insights by Mark Eisenberg 25.06.2024 **Is Now a Good Time to Invest? Expert Dr. Jeff Jones says yes! Focus on diversifying your portfolio, stay calm, ...
US Clarifies Antitrust Enforcement in Meatpacking Industry by Mark Eisenberg 25.06.2024 USDA's new rule plans to help farmers challenge unfair meatpacking practices, aiming for fairer markets and increased competition in the ...
AI in Medical Diagnostics Market to Hit $30.76B by 2032, Led by Software by Lilu Anderson 25.06.2024 "AI in Medical Diagnostics set to skyrocket to USD 30.76 billion by 2032, driven by rapid advancements and major industry ...
AI Hardware Market Poised to Surpass USD 84.9 Billion by 2031 by Lilu Anderson 25.06.2024 Global AI hardware market to grow from $13.3B in 2022 to $84.9B by 2031, driven by advances in tech and ...
Pertamina Unveils Sustainable Finance Framework for Green Projects by Mark Eisenberg 25.06.2024 Pertamina's Sustainable Finance Framework aids green projects through green loans and bonds, aiming for a 32% emissions cut by 2030.
Inside the British Library Cyberattack: Key Takeaways & Fallout by Lilu Anderson 25.06.2024 British Library cyberattack reveals costly security flaws; lessons in technical debt, holistic risk assessment, information governance, and defense in depth.
Bitcoin Dips Below $60K: June 2024 Price Analysis by John Darbie 25.06.2024 "Bitcoin drops below $60K amid bearish pressure. Analyze BTC’s future with key support, resistance levels, and market dynamics. Stay informed!"
Alnylam’s HELIOS-B Review: Conflicting Insights Analyzed by Lilu Anderson 25.06.2024 Explore conflicting analyst opinions on Alnylam's HELIOS-B data, contrasting efficacy views for vutrisiran in addressing ATTR-CM treatments.